SBC Stock Analysis: Buy, Sell, or Hold?
SBC - SBC Medical Group Holdings Incorporated Common Stock
$4.15
0.15 (3.75%)
▲
5d:
+13.7%
30d:
+35.62%
90d:
+35.18%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When SBC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: SBC is 15.3% above its trading range ($3.60). Market expects -0.3% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: SBC is 15.3% above its trading range ($3.60). Market expects -0.3% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.52
Based on 4.1% avg growth
INTRINSIC VALUE TODAY
$2.80
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBC is currently trading at $4.15, which is considered extended relative to its 30-day fair value range of $2.93 to $3.60. The stock's valuation (Forward PE: 7.5) is in line with its historical norms (7.6). Remarkably, the market is currently pricing in an annual earnings decline of 0.3% over the next few years. This pessimistic expectation contrasts with the company's recent 338.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, SBC is in a downtrend. The price is approaching resistance at $4.06. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: SBC scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.50 (+132.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SBC is in a downtrend. The price is approaching resistance at $4.06. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: SBC scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.50 (+132.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.93 -
$3.60
Company Quality Score
26/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
23.8%
All Signals
- BEARISH: Price significantly overextended (+15.3% above its trading range)
- BEARISH: Weak technical setup (5/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.8%)
- BULLISH: Trading 132.9% below Wall St target ($8.50)
- WARNING: Composite score 26/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.93 -
$3.60
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.02
Resistance Level
$4.06
Current Trend
Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.53
Wall Street Target
$8.50
(+132.9%)
Revenue Growth (YoY)
13.4%
Earnings Growth (YoY)
338.9%
Profit Margin
28.0%
Valuation Discount vs History
-0.3% cheaper
PE vs Historical
7.5 vs 7.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.3%
(market-implied from PE analysis)
1-Year Target
$3.64
(0%)
2-Year Target
$3.63
(-1%)
3-Year Target
$3.62
(-1%)
3-Yr Target (if PE normalizes)
(PE: 8→8)
$3.65
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 4.3%)
$11.07
(+203%)
Base:
(SPY PE: 7.5, Growth: 4.3%)
$4.14
(+14%)
Bear:
(PE: 6.4, Growth: 4.3%)
$3.52
(-4%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (8x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 7.62 | Current EPS (TTM): $0.48
Bull Case
$4.07
(+2%)
Analyst growth 1.0%, PE expands to 8.4
Base Case
$3.70
(-8%)
Market implied 1.0%, PE stable at 7.6
Bear Case
$2.49
(-38%)
Severe decline -20.0%, PE contracts to 6.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.5 to 7.6
Stabilization Target:
$3.69
(+1.0%)
PE Expansion Potential:
+1.0%
Share & Embed Analysis
Last updated: August 24, 2026 12:56 PM ET
Data refreshes hourly during market hours. Next update: 1:56 PM
Data refreshes hourly during market hours. Next update: 1:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Yoshiyuki Aikawa
SELL
3100000 shares
2026-04-21
Yoshiyuki Aikawa
SELL
4422900 shares
2026-03-06
Top Rated Consulting Services Stocks
Top-rated stocks in Consulting Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EFX
Equifax Inc |
BUY
23 analysts |
$212 | 45 HOLD |
|
VRSK
Verisk Analytics Inc |
HOLD
18 analysts |
$238 | 64 BUY |
|
HURN
Huron Consulting Group I… |
STRONG BUY
5 analysts |
$191 | 42 HOLD |
|
BAH
Booz Allen Hamilton Hold… |
HOLD
14 analysts |
$86 | 41 HOLD |
|
ICFI
ICF International Inc |
BUY
5 analysts |
$107 | 36 SELL |
